MA39111A1 - Dispositif oculaire - Google Patents

Dispositif oculaire

Info

Publication number
MA39111A1
MA39111A1 MA39111A MA39111A MA39111A1 MA 39111 A1 MA39111 A1 MA 39111A1 MA 39111 A MA39111 A MA 39111A MA 39111 A MA39111 A MA 39111A MA 39111 A1 MA39111 A1 MA 39111A1
Authority
MA
Morocco
Prior art keywords
eye
delivery device
drug delivery
polymer
intraocular drug
Prior art date
Application number
MA39111A
Other languages
English (en)
Inventor
Jean-Marie Rakic
Jean-Michel Foidart
Original Assignee
Eyed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyed Pharma filed Critical Eyed Pharma
Publication of MA39111A1 publication Critical patent/MA39111A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes
    • A61F2240/005—Templates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un dispositif d'administration de médicaments intraoculaire à libération prolongée comprenant : (a) un cœur de matrice polymère dans lequel au moins un agent thérapeutique est mélangé, et ; (b) un enduit polymère entourant complètement ledit matériau de matrice polymère ; ledit cœur de matrice polymère et l'enduit polymère étant insolubles et inertes dans les fluides oculaires, et le dispositif d'administration de médicaments intraoculaire à libération prolongée ayant la forme d'un segment annulaire souple et devant être inséré dans le sulcus de l'œil intact et/ou de l'oeil pseudophaque.
MA39111A 2013-11-14 2014-11-14 Dispositif oculaire MA39111A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13192889 2013-11-14
PCT/EP2014/074644 WO2015071427A1 (fr) 2013-11-14 2014-11-14 Dispositif oculaire

Publications (1)

Publication Number Publication Date
MA39111A1 true MA39111A1 (fr) 2017-04-28

Family

ID=49584627

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39111A MA39111A1 (fr) 2013-11-14 2014-11-14 Dispositif oculaire

Country Status (17)

Country Link
US (1) US9999595B2 (fr)
EP (2) EP3566693B1 (fr)
JP (1) JP6602761B2 (fr)
KR (1) KR20160085870A (fr)
CN (1) CN105792812B (fr)
AU (1) AU2014350095B9 (fr)
BR (1) BR112016010638B1 (fr)
CA (1) CA2929684C (fr)
CL (1) CL2016001160A1 (fr)
EA (1) EA032183B1 (fr)
ES (2) ES2864274T3 (fr)
HK (1) HK1223271A1 (fr)
IL (1) IL245405A0 (fr)
MA (1) MA39111A1 (fr)
MX (1) MX2016006142A (fr)
TN (1) TN2016000162A1 (fr)
WO (1) WO2015071427A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10507101B2 (en) 2014-10-13 2019-12-17 W. L. Gore & Associates, Inc. Valved conduit
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US11406533B2 (en) 2017-03-17 2022-08-09 W. L. Gore & Associates, Inc. Integrated aqueous shunt for glaucoma treatment
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
CN111971026A (zh) 2018-05-24 2020-11-20 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
AU2019275409B2 (en) 2018-05-24 2024-08-15 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
JP2021532853A (ja) 2018-07-23 2021-12-02 ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド，ア ボディ コーポレイト 薬物送達のための眼科用装置
US11678983B2 (en) 2018-12-12 2023-06-20 W. L. Gore & Associates, Inc. Implantable component with socket
BR112021026265A2 (pt) 2019-06-27 2022-06-14 Layerbio Inc Métodos e sistemas de entrega de dispositivos oculares
US11399977B2 (en) 2020-06-04 2022-08-02 SpyGlass Pharma, Inc. Ophthalmic implant system for drug delivery
WO2023091333A1 (fr) * 2021-11-17 2023-05-25 Celanese Eva Performance Polymers Llc Dispositif implantable pour le traitement d'une maladie oculaire inflammatoire
CN114224822B (zh) * 2022-01-28 2023-07-14 复旦大学附属眼耳鼻喉科医院 一种眼部缓释给药植入物及其制造方法
EP4233836A1 (fr) * 2022-02-24 2023-08-30 Eyed Pharma Dispositif d'administration intraoculaire de medicament comprenant un oeillet
WO2024020505A2 (fr) * 2022-07-22 2024-01-25 SpyGlass Pharma, Inc. Systèmes d'administration de médicament intraoculaire et méthodes d'utilisation

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4668506A (en) 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4718905A (en) * 1986-08-13 1988-01-12 Freeman Jerre M Haptic element using ion beam implantation for an intraocular lens
US4997652A (en) 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5928282A (en) * 1997-06-13 1999-07-27 Bausch & Lomb Surgical, Inc. Intraocular lens
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
FR2787991B1 (fr) * 1998-12-31 2001-05-25 Medicale De Prec S M P Sa Soc Dispositif pour traiter la presbytie ou autre affection oculaire
CA2473355C (fr) * 2002-01-18 2012-01-03 Michael E. Snyder Dispositif ophtalmologique a liberation prolongee et son procede de fabrication et d'utilisation
FR2844703B1 (fr) * 2002-09-25 2005-07-08 Alain Nicolas Gilg Dispositif intraoculaire pour restaurer l'accommodation de l'oeil atteint de presbytie
US20090018650A1 (en) * 2003-06-19 2009-01-15 Boxer Wachler Brian S Ophthalmological zonular stretch segment for treating presbyopia
JP2008535847A (ja) * 2005-04-08 2008-09-04 サーモディクス，インコーポレイティド 網膜下に送達するための持続放出インプラント
WO2009140246A2 (fr) * 2008-05-12 2009-11-19 University Of Utah Research Foundation Dispositif d'administration intraoculaire de médicament et procédés associés
EP2334285A1 (fr) * 2008-09-12 2011-06-22 Critical Pharmaceuticals Limited Améliorations apportées à l absorption d'agents thérapeutiques à travers des membranes de muqueuses ou à travers la peau
WO2010101758A1 (fr) 2009-03-03 2010-09-10 Alcon Research, Ltd. Dispositif péricornéen d'administration de médicaments
AU2011237788A1 (en) * 2010-04-06 2012-11-01 Allergan, Inc. Sustained-release reservoir implants for intracameral drug delivery

Also Published As

Publication number Publication date
BR112016010638B1 (pt) 2023-01-31
CN105792812A (zh) 2016-07-20
IL245405A0 (en) 2016-06-30
BR112016010638A2 (fr) 2017-08-08
MX2016006142A (es) 2016-12-09
EA032183B1 (ru) 2019-04-30
JP2016537370A (ja) 2016-12-01
EP3566693A1 (fr) 2019-11-13
TN2016000162A1 (en) 2017-10-06
WO2015071427A1 (fr) 2015-05-21
CA2929684C (fr) 2022-02-22
CN105792812B (zh) 2020-10-23
EP3068372B1 (fr) 2019-05-08
AU2014350095B2 (en) 2019-08-29
KR20160085870A (ko) 2016-07-18
US9999595B2 (en) 2018-06-19
ES2864274T3 (es) 2021-10-13
AU2014350095B9 (en) 2019-09-12
AU2014350095A1 (en) 2016-06-09
CA2929684A1 (fr) 2015-05-21
JP6602761B2 (ja) 2019-11-06
HK1223271A1 (zh) 2017-07-28
EA201690967A1 (ru) 2016-10-31
EP3566693B1 (fr) 2021-02-17
ES2740352T3 (es) 2020-02-05
US20160287513A1 (en) 2016-10-06
CL2016001160A1 (es) 2017-03-17
EP3068372A1 (fr) 2016-09-21

Similar Documents

Publication Publication Date Title
MA39111A1 (fr) Dispositif oculaire
USD839294S1 (en) Display screen with graphical user interface for closed-loop medication delivery
MA49677A (fr) Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé
EP4233988A3 (fr) Pompes à sang
WO2008144340A3 (fr) Système de distribution de médicament comprenant une lentille sclérale
MA51900A (fr) Dispositif d'administration de médicament à élément détecté
EP3999143A4 (fr) Dispositif de pancréas artificiel en boucle fermée, doté d'une détection et d'une perfusion intégrées
WO2014179568A3 (fr) Implant oculaire à deux couches
EP3000497A3 (fr) Détection d'insertion d'une canule
MA39059A1 (fr) Système d'administration de médicament.
AR053304A1 (es) Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
EP2639626A3 (fr) Zones de fluide dynamique dans des lentilles de contact
RU2016148324A (ru) Предварительно заполненный пластиковый шприц, содержащий антагонист vegf
MA51131A (fr) Dispositif d'administration de médicament doté d'un système de détection de seringue
PE20060523A1 (es) Formas farmaceuticas orales de opioides con liberacion controlada
EP2671507A3 (fr) Système pharma-informatique
JP2013542764A5 (fr)
RU2018121813A (ru) Предварительно заполненный пластиковый шприц, содержащий антагонист vegf
CY1121654T1 (el) Διαδερματικα συστηματα αποτρεπτικα καταχρησης και εσφαλμενης χρησης
FR2928536B1 (fr) Dispositif d'injection dans l'oeil
MA54245A (fr) Système d'administration transdermique de médicaments à régulation thermique
MA53818A (fr) Dispositif d'administration de médicament ayant un indicateur de dose
PH12016500869A1 (en) Methods of treatment of ocular conditions with a sustained drug delivery implant
JP2014166350A5 (fr)
WO2015102963A3 (fr) Dispositif support de perfusion et procédé associé